Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest
- PMID: 14522931
Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest
Abstract
The epothilones are a group of novel microtubule-targeted, antimitotic compounds that have a paclitaxel-like, assembly enhancing effect on tubulin in vitro as well as in cultured cells. We hypothesize that epothilones induce mitotic arrest by suppressing microtubule dynamics. To test this hypothesis, we used MCF7 cells stably transfected with GFP-alpha-tubulin to analyze microtubule dynamics at three concentrations of epothilone B, one that induced no mitotic arrest (0.2 nM, 20 h), one that induced one-third maximal mitotic arrest (IC(33,) 2 nM, 20 h), and one that induced half-maximal mitotic arrest (IC(50,) 3.5 nM, 20 h). We found that epothilone B suppressed microtubule dynamics in a concentration-dependent manner coincident with mitotic block. At 0.2 nM epothilone B, dynamics were not significantly altered. At 2 nM epothilone B (IC(33)), the mean growth and shortening rates were decreased by 38 and 27%, respectively. Dynamicity was decreased by 47%. At the IC(50), 80% of the cells had nearly complete stabilization of microtubule dynamics, and no anaphase or telophase figures were observed. Comparison of the effects of epothilone B on microtubule dynamics with those of paclitaxel indicated that both drugs alter the same microtubule dynamic parameters to a similar extent. At the IC(50) for mitotic arrest, dynamicity was reduced by 54% by paclitaxel compared with 62% for epothilone B. In 65% of the cells treated with paclitaxel, the microtubules were completely stabilized. Thus, the effects of epothilone B on microtubule dynamics are remarkably similar to those of paclitaxel, suggesting that both drugs induce mitotic block by a similar mechanism.
Similar articles
-
Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs.Cancer Res. 2002 Apr 1;62(7):1935-8. Cancer Res. 2002. PMID: 11929805
-
Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells.Cancer Res. 2005 Mar 15;65(6):2433-40. doi: 10.1158/0008-5472.CAN-04-2624. Cancer Res. 2005. PMID: 15781659
-
Suppression of centromere dynamics by Taxol in living osteosarcoma cells.Cancer Res. 2003 Jun 1;63(11):2794-801. Cancer Res. 2003. PMID: 12782584
-
Epothilones as lead structures for the synthesis-based discovery of new chemotypes for microtubule stabilization.Acc Chem Res. 2008 Jan;41(1):21-31. doi: 10.1021/ar700157x. Epub 2007 Dec 27. Acc Chem Res. 2008. PMID: 18159935 Review.
-
Preclinical investigations with epothilones in breast cancer models.Semin Oncol. 2008 Apr;35(2 Suppl 2):S15-21; quiz S39. doi: 10.1053/j.seminoncol.2008.02.002. Semin Oncol. 2008. PMID: 18410795 Review.
Cited by
-
Specific β-tubulin isotypes can functionally enhance or diminish epothilone B sensitivity in non-small cell lung cancer cells.PLoS One. 2011;6(6):e21717. doi: 10.1371/journal.pone.0021717. Epub 2011 Jun 29. PLoS One. 2011. PMID: 21738778 Free PMC article.
-
Inhibition of centromere dynamics by eribulin (E7389) during mitotic metaphase.Mol Cancer Ther. 2008 Jul;7(7):2003-11. doi: 10.1158/1535-7163.MCT-08-0095. Mol Cancer Ther. 2008. PMID: 18645010 Free PMC article.
-
An antitubulin agent BCFMT inhibits proliferation of cancer cells and induces cell death by inhibiting microtubule dynamics.PLoS One. 2012;7(8):e44311. doi: 10.1371/journal.pone.0044311. Epub 2012 Aug 31. PLoS One. 2012. PMID: 22952952 Free PMC article.
-
Peloruside A inhibits microtubule dynamics in a breast cancer cell line MCF7.Invest New Drugs. 2011 Aug;29(4):615-26. doi: 10.1007/s10637-010-9398-2. Epub 2010 Feb 20. Invest New Drugs. 2011. PMID: 20169398
-
New therapeutic options for chemotherapy-resistant metastatic breast cancer: the epothilones.Drugs. 2008;68(2):139-46. doi: 10.2165/00003495-200868020-00001. Drugs. 2008. PMID: 18197722 Review.